Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis.

Area of Science:

• Cancer Biology
• Epigenetics
• Genomics

Background:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer death, with frequent metastasis to the brain.
• Understanding the mechanisms of NSCLC brain metastasis is crucial for improving patient outcomes.
• Epigenetic dysregulation, including DNA methylation changes, is implicated in cancer development and spread.

Purpose of the Study:

• To investigate the role of altered DNA methylation in NSCLC brain metastasis.
• To identify recurrent epigenetic changes associated with NSCLC progression to the brain.

Main Methods:

• Global DNA methylation profiling of normal lung, primary lung tumor, and brain metastasis samples from 12 NSCLC patients.
• Analysis of DNA methylation patterns in relation to genomic features, including DNA methylation valleys (DMVs) and histone modifications (H3K9me3, H3K27me3, H3K4me1).
• Investigation of EZH2 occupancy and DNA methylation changes in a lymph node-derived NSCLC cell line.

Main Results:

• DNA methylation variations during metastatic spread were similar to primary tumorigenesis but less coordinated.
• Recurrent methylation gains were observed in DMVs harboring H3K9me3, H3K27me3, and H3K4me1 marks during metastatic progression.
• Loss of EZH2 binding in DMVs correlated with increased DNA methylation, suggesting epigenetic switching and altered regulation of developmental genes.

Conclusions:

• Altered DNA methylation patterns, particularly gains in DMVs, are characteristic of NSCLC brain metastasis.
• Epigenetic dysregulation of developmental genes may confer a selective advantage for metastasis and survival.
• Identified methylation patterns may serve as prognostic biomarkers for NSCLC brain metastasis.